Literature DB >> 21616454

Polymyxin B for endotoxin removal in sepsis.

Jean-Marc Cavaillon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21616454     DOI： 10.1016/S1473-3099(11)70131-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management.

Authors:  Soracha Thamphiwatana; Pavimol Angsantikul; Tamara Escajadillo; Qiangzhe Zhang; Joshua Olson; Brian T Luk; Sophia Zhang; Ronnie H Fang; Weiwei Gao; Victor Nizet; Liangfang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

Review 2.  Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect.

Authors:  James C Hurley
Journal:  Toxins (Basel)       Date:  2013-12-18       Impact factor: 4.546

3.  Hypothetical protein Cpn0423 triggers NOD2 activation and contributes to Chlamydia pneumoniae-mediated inflammation.

Authors:  Hong-Liang Chen; Guo-Zhi Dai; An-Wen Zhou; Ran-Hui Li; Hong-Xia Yuan; Jing Xiang; Xiao-Xing You; Ou Ran; Yi-Mou Wu
Journal:  BMC Microbiol       Date:  2017-07-11       Impact factor: 3.605

4.  The immunomodulatory activity of meningococcal lipoprotein Ag473 depends on the conformation made up of the lipid and protein moieties.

Authors:  Ching-Liang Chu; Yen-Ling Yu; Yueh-Chen Kung; Pei-Yu Liao; Ko-Jiunn Liu; Yen-Tzu Tseng; Yuan-Chuen Lin; Steve Shih-Yang Hsieh; Pele Choi-Sing Chong; Chiou-Ying Yang
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.